Why the study?
Do beta-blockers prevent the reoccurrence of Takotsubo cardiomyopathy in patients undergoing electroconvulsive therapy?
Do beta-blockers prevent the reoccurrence of Takotsubo cardiomyopathy in patients undergoing electroconvulsive therapy?
Answers are grounded in this paper and cite their sources.
Takotsubo cardiomyopathy is a serious potential complication of electroconvulsive therapy, especially in postmenopausal women, which may potentially be prevented by beta-blockers.
Takotsubo cardiomyopathy is a serious but transient potential complication of electroconvulsive therapy. Limited evidence indicates that β-adrenergic receptor blocking agents may help prevent its reoccurrence in patients needing further electroconvulsive treatment. Health care providers in psychiatry should be aware of this potential complication of electroconvulsive therapy, especially in postmenopausal women. However, many questions remain regarding this issue.
No takes yet. Share an insight, caveat, or question.
Sharp et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: